These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34854435)

  • 1. Potential therapeutic application of mesenchymal stem cells in COVID-19 complications.
    Kolanko E; Mazurski A; Czekaj P
    Med Pr; 2021 Dec; 72(6):693-700. PubMed ID: 34854435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients.
    Heidari F; Heidari R; Sabet MN; Hamidieh AA; Saltanatpour Z
    Curr Stem Cell Res Ther; 2024; 19(5):644-652. PubMed ID: 37073149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment.
    Fang Y; Lao P; Tang L; Chen J; Chen Y; Sun L; Tan W; Fan X
    Cell Transplant; 2023; 32():9636897231184611. PubMed ID: 37395459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
    Warrier S; Mohana Sundaram S; Varier L; Balasubramanian A
    Placenta; 2022 Jan; 117():161-168. PubMed ID: 34915433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell treatment for COVID-19.
    Xu R; Feng Z; Wang FS
    EBioMedicine; 2022 Mar; 77():103920. PubMed ID: 35279630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical progress: Stem cells as a new therapeutic strategy for COVID-19.
    Musial C; Gorska-Ponikowska M
    Stem Cell Res; 2021 Apr; 52():102239. PubMed ID: 33601098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19.
    Zendedel E; Tayebi L; Nikbakht M; Hasanzadeh E; Asadpour S
    Curr Stem Cell Res Ther; 2024; 19(8):1055-1071. PubMed ID: 37815188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.
    Abdelgawad M; Bakry NS; Farghali AA; Abdel-Latif A; Lotfy A
    Stem Cell Res Ther; 2021 Aug; 12(1):469. PubMed ID: 34419143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.
    Wang W; Lei W; Jiang L; Gao S; Hu S; Zhao ZG; Niu CY; Zhao ZA
    J Transl Med; 2021 May; 19(1):198. PubMed ID: 33971907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells and their derived exosomes to combat Covid-19.
    Yousefi Dehbidi M; Goodarzi N; Azhdari MH; Doroudian M
    Rev Med Virol; 2022 Mar; 32(2):e2281. PubMed ID: 34363275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19.
    Li JP; Wu KH; Chao WR; Lee YJ; Yang SF; Chao YH
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
    Rocha JLM; de Oliveira WCF; Noronha NC; Dos Santos NCD; Covas DT; Picanço-Castro V; Swiech K; Malmegrim KCR
    Stem Cell Rev Rep; 2021 Feb; 17(1):71-93. PubMed ID: 32895900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future.
    Beghini DG; Horita SI; Henriques-Pons A
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients.
    Esquivel D; Mishra R; Soni P; Seetharaman R; Mahmood A; Srivastava A
    Stem Cell Rev Rep; 2021 Feb; 17(1):144-152. PubMed ID: 32740890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells: Biological characteristics and application in disease therapy.
    Lou S; Duan Y; Nie H; Cui X; Du J; Yao Y
    Biochimie; 2021 Jun; 185():9-21. PubMed ID: 33711361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications.
    Chen L; Qu J; Kalyani FS; Zhang Q; Fan L; Fang Y; Li Y; Xiang C
    Cell Mol Life Sci; 2022 Feb; 79(3):142. PubMed ID: 35187617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment.
    Chinnici CM; Russelli G; Bulati M; Miceli V; Gallo A; Busà R; Tinnirello R; Conaldi PG; Iannolo G
    World J Gastroenterol; 2021 May; 27(17):1905-1919. PubMed ID: 34007129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.
    Majolo F; da Silva GL; Vieira L; Timmers LFSM; Laufer S; Goettert MI
    Stem Cell Rev Rep; 2021 Feb; 17(1):44-55. PubMed ID: 32827081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.